Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy
Author(s) -
Emma J. Birks,
Robert S. George,
M. Hedger,
Toufan Bahrami,
P. Wilton,
Christopher T. Bowles,
Carole Webb,
Robert Bougard,
Mohammed Amrani,
Magdi H. Yacoub,
Gilles Dreyfus,
Asghar Khaghani
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.933960
Subject(s) - medicine , heart failure , ejection fraction , ventricular assist device , cardiology , pulmonary wedge pressure , inotrope , dilated cardiomyopathy , cardiac index , extracorporeal membrane oxygenation , myocardial infarction , hemodynamics , cardiac output
We have previously shown that a specific combination of drug therapy and left ventricular assist device unloading results in significant myocardial recovery, sufficient to allow pump removal, in two thirds of patients with dilated cardiomyopathy receiving a Heartmate I pulsatile device. However, this protocol has not been used with nonpulsatile devices.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom